Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Redcliffe-Labs"

5 News Found

Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India
News | September 23, 2023

Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India

Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health

Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test
Diagnostic Center | February 21, 2023

Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test

Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test

Skye Air Mobility to deploy drones to enhance Redcliffe Labs services
Diagnostic Center | February 10, 2022

Skye Air Mobility to deploy drones to enhance Redcliffe Labs services

Urban, semi-urban and remote corners of the country will be catered using drone delivery technology

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
People | February 07, 2022

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer

Takes charge to lead business innovation, strategy, alliance & partnerships

Redcliffe Labs chalks out aggressive expansion plans
Diagnostic Center | December 08, 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months

Latest Stories

Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake

RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr

Novartis to acquire Mariana Oncology for upfront US$ 1 billion

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging